Novel Acid Blocker Shows Promise for Non-Erosive Reflux Disease
A recent phase III clinical trial indicates that once-daily oral administration of tegoprazan, a novel potassium-competitive acid blocker, significantly decreases
A recent phase III clinical trial indicates that once-daily oral administration of tegoprazan, a novel potassium-competitive acid blocker, significantly decreases
Industry groups are stepping in to provide direction on advanced artificial intelligence tools as federal oversight continues to evolve. Recently,
Zimmer and Think Surgical have signed a multi-year extension of their ongoing agreement regarding robotic surgery technology. The collaboration centers
A recent phase III clinical trial indicates that once-daily oral administration of tegoprazan, a novel potassium-competitive acid blocker, significantly decreases
The United States Food and Drug Administration has introduced a new strategic framework aimed at transforming how regulators evaluate treatments
Efforts to build more sustainable and equitable urban food systems are reaching a new milestone with the upcoming launch of
